Kil Hun Lee

Kil Hun Lee

Auto-generated profile, based on publicly available information

Kil Hun Lee

Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JLJu Hee Lee
Ju Hee Lee
JHJi Hae Hwang
Ji Hae Hwang
EJEun Jung Jang
Eun Jung Jang
RKRyu Kyung Kim
Ryu Kyung Kim
KLKil Hun Lee
Kil Hun Lee
YPYoung-Joon Park
Young-Joon Park
Lee JH, et al. J Korean Med Sci. 2023 Aug;38(34):e269. https://doi.org/10.3346/jkms.2023.38.e269

10 August 2023 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
CCChungman Chae
Chungman Chae
RKRyu Kyung Kim
Ryu Kyung Kim
EJEun Jung Jang
Eun Jung Jang
JSJi Ae Shim
Ji Ae Shim
EPEunkyung Park
Eunkyung Park
DKDonghyok Kwon
Donghyok Kwon
To compare the effectiveness of bivalent and monovalent COVID-19 vaccines throughout the 2022-2023 winter season based on real-world data. This retrospective observational matched cohort study used the national vaccination program and a surveillance dataset from the Republic of Korea, and included adults aged >18 years who received bivalent or monovalent COVID-19 vaccines between October 11, 2022, and December 17, 2022. Cox proportional hazard models were used to estimate the hazard ratio for COVID-19 infection between the groups. We included 29,245 matched individuals in the bivalent and monovalent vaccine groups, respectively. The bivalent vaccine recipients showed 12.2% (95% confidence interval [CI] 6.5-17.7%) additional protection against COVID-19 infection compared with the monovalent vaccine recipients. The additional protection provided by bivalent vaccines was significantly higher among residents of long-term care facilities (39.4%, 95% CI 21.6-53.1%). Maximum additional protection was observed 3 to 4 months after completing the vaccination (17.6%, 95% CI 6.6-27.3%). Bivalent COVID-19 vaccines showed significantly better protection against infection than monovalent vaccines among adults during the 2022-2023 winter season. Our results highlight that immunization programs with bivalent vaccines comprising recent variants can be an effective measure to prepare for seasonal COVID-19 circulation.

1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
RKRyu Kyung Kim
Ryu Kyung Kim
YCYoung June Choe
Young June Choe
EJEun Jung Jang
Eun Jung Jang
CCChungman Chae
Chungman Chae
JHJi Hae Hwang
Ji Hae Hwang
DKDonghyok Kwon
Donghyok Kwon
Kim RK, et al. J Korean Med Sci. 2023 Nov;38:e396. https://doi.org/10.3346/jkms.2023.38.e396

30 June 2023 in Osong Public Health and Research Perspectives
Verified
Journal Article
Open access
JHJi Hae Hwang
Ji Hae Hwang
JLJu Hee Lee
Ju Hee Lee
EJEun Jung Jang
Eun Jung Jang
RKRyu Kyung Kim
Ryu Kyung Kim
KLKil Hun Lee
Kil Hun Lee
YPYoung-Joon Park
Young-Joon Park
Objectives: The Korea Disease Control and Prevention Agency promotes vaccination by regularly providing information on its benefits for reducing the severity of coronavirus disease 2019 (COVID-19). This study aimed to analyze the number of averted severe COVID-19 cases and COVID-19-related deaths by age group and quantify the impact of Republic of Korea’s nationwide vaccination campaign.Methods: We analyzed an integrated database from the beginning of the vaccination campaign on February 26, 2021 to October 15, 2022. We estimated the cumulative number of severe cases and COVID-19-related deaths over time by comparing observed and estimated cases among unvaccinated and vaccinated groups using statistical modeling. We compared daily age-adjusted rates of severe cases and deaths in the unvaccinated group to those in the vaccinated group and calculated the susceptible population and proportion of vaccinated people by age.Results: There were 23,793 severe cases and 25,441 deaths related to COVID-19. We estimated that 119,579 (95% confidence interval [CI], 118,901–120,257) severe COVID-19 cases and 137,636 (95% CI, 136,909–138,363) COVID-19-related deaths would have occurred if vaccination had not been performed. Therefore, 95,786 (95% CI, 94,659–96,913) severe cases and 112,195 (95% CI, 110,870–113,520) deaths were prevented as a result of the vaccination campaign.Conclusion: We found that, if the nationwide COVID-19 vaccination campaign had not been implemented, the number of severe cases and deaths would have been at least 4 times higher. These findings suggest that Republic of Korea’s nationwide vaccination campaign reduced the number of severe cases and COVID-19 deaths.